Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis.
Phase of Trial: Phase II/III
Latest Information Update: 24 Mar 2012
At a glance
- Drugs Memantine; Riluzole
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms MEDALS
- 24 Mar 2012 Additional lead trial investigator (Jorge Matias-Guiu Guia) identified as reported by European Clinical Trials Database record.
- 24 Mar 2012 Planned number of patients changed from 60 to 140 as reported by European Clinical Trials Database record.
- 08 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.